Presenter: Bruce R. Conklin MD
  Gladstone Institutes &UCSF Innovative Genomics Institute

 

Session Objectives:
As a result of this program, participants will be able to:

1. Define the role of human iPS cells to advance the development of gene therapy

2. Describe the mechanism of CRISPR/Cas9

3. Explore the unique challenges of using CRISPR for gene-editinge

4. Consider future clinical implications of gene-editing in humans

 


Planning Committee:
Emily Chen, MD - Genetics, Kaiser Permanente, San Francisco
Kimberly Barr, MS, LCGC - Regional Genetics Education Coordinator, Kaiser Permanente, Northern California
Lisa Roberts, MAEd - Practice Leader, TPMG Physician Education & Development

Target Audience:
Medical geneticists; Genetic counselors; Laboratory geneticists, directors, technicians, and technologists; Pathologists; Nurses; Physicians of all specialties with an interest in genetics, genomics, and the genetic basis of disease; Others with an interest in the science and art of medical genetics and genomics.

Credit Information:

To receive CEU or CME Credit an online survey must be completed within 10 days of the webinar.  
No CME credit is offered for viewing a recorded session.

TPMG Physician Education and Development is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. 
TPMG Physician Education and Development designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit(s)TMper session. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This live activity is co-provided by the Kaiser Permanente National CME Program. 
 

Nurses may report up to a maximum total of 1.0 hours of credit towards the continuing medical education requirements for license renewal by the California Board of Registered Nurses.

Genetic Counselors: This event has been approved by the National Society of Genetic Counselors (NSGC) for Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification.

NOTE: A CEU fee of $25 per participant paid to the National Society of Genetic Counselors is collected at the end of the 2018 webinar series for the filing and awarding of CEU certificates. 


DISCLOSURE:
Faculty for TPMG Continuing Medical Education Programs must complete a Declaration of Disclosure prior to the CME activity. Having an interest in or affiliation with a commercial entity does not preclude making a presentation at a CME activity, but if a Conflict of Interest exists, it must be resolved prior to the educational activity being delivered. Relevant financial relationships, or the lack of such relationships, must be disclosed to learners prior to the beginning of the educational activity. Dr. Bruce Conklin was formerly a science advisory board member & founder and still receives milestone payments from iPierian/ True North Inc. In addition, he is a current science advisory board member and received stock options for Scientist.com; Cellogy Inc.; CODA Therapeutics; as well as Tenaya Therapeutics. TPMG Physician Education & Development has determined that all other speakers, committee members & consultants for this program do not have any affiliations with any corporate organization that may constitute a conflict of interest with this program. Kaiser Permanente does not endorse any brand name products. Kaiser Permanente does not endorse any brand-name products.

 

Session date: 
Tuesday, January 9, 2018 - 12:30am to 1:30am

Please login or register to take this course.
CME Office: